CLINICAL TRIALS PROFILE FOR DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

All Clinical Trials for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00075803 ↗	Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)	Completed	Blood and Marrow Transplant Clinical Trials Network	Phase 3	2003-11-01	The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio.
NCT00075803 ↗	Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)	Completed	National Cancer Institute (NCI)	Phase 3	2003-11-01	The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio.
NCT00075803 ↗	Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	2003-11-01	The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio.
NCT00075803 ↗	Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)	Completed	National Marrow Donor Program	Phase 3	2003-11-01	The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio.
NCT00075803 ↗	Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)	Completed	Medical College of Wisconsin	Phase 3	2003-11-01	The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio.
NCT00166166 ↗	Endothelial Hyperpolarization in Humans	Terminated	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2	2002-07-01	The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF.
NCT00166166 ↗	Endothelial Hyperpolarization in Humans	Terminated	Emory University	Phase 2	2002-07-01	The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF.

Clinical Trial Conditions for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Condition Name

Condition Name for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Intervention	Trials
Candidiasis	5
Fungal Infection	4
Candidemia	3
Healthy	3

Condition MeSH

Condition MeSH for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Intervention	Trials
Candidiasis	14
Mycoses	9
Infections	5
Infection	5

Clinical Trial Locations for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Trials by Country

Trials by Country for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Location	Trials
United States	157
Canada	14
Brazil	5
Italy	4
Spain	4

Trials by US State

Trials by US State for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Location	Trials
California	9
Florida	8
Texas	8
Pennsylvania	8
North Carolina	8

Clinical Trial Progress for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	11
Phase 2	4

Clinical Trial Status

Clinical Trial Status for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Completed	27
Not yet recruiting	4
Unknown status	3

Clinical Trial Sponsors for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Sponsor	Trials
Pfizer	4
Astellas Pharma Inc	3
National Cancer Institute (NCI)	3

Sponsor Type

Sponsor Type for DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Sponsor	Trials
Other	45
Industry	25
NIH	10